GlaxoSmithKline S.A.E (EGX: BIOC)

GlaxoSmithKline S.A.E Revenue

GlaxoSmithKline S.A.E had revenue of 787.08M EGP in the quarter ending September 30, 2024, with 36.54% growth. This brings the company's revenue in the last twelve months to 2.81B, up 32.13% year-over-year. In the year 2023, GlaxoSmithKline S.A.E had annual revenue of 2.24B with 22.87% growth.

• Revenue (ttm): 2.81B
• Revenue Growth: +32.13%
• P/S Ratio: 1.21
• Revenue / Employee: 3.51M
• Employees: 800
• Market Cap: 3.39B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.24B	416.99M	22.87%
Dec 31, 2022	1.82B	11.19M	0.62%
Dec 31, 2021	1.81B	-180.79M	-9.07%
Dec 31, 2020	1.99B	288.80M	16.95%
Dec 31, 2019	1.70B	80.66M	4.97%